Abstract
This review will focus on glutathione depletion performed in different biological systems to elucidate molecular implications of this tripeptide on physiological and pathological processes. Cellular and molecular changes produced in liver, brain and kidney by glutathione depleting drugs, such as D,Lbuthionine- S,R-sulfoximine, menadione and acetaminophen, will be described. Special attention will be given to the inhibitory mechanisms produced by those drugs on intestinal calcium absorption and alkaline phosphatase activity. The role of DL-buthionine-S,R-sulfoximine and menadione on mechanisms of apoptosis, reactive oxygen species production and mitochondrial function from mammalian breast cancer cells will be analyzed. Finally, reversion or prevention of some of the previous effects by administration of lipoic acid, glutathione monoester, KR31378 and 2(RS)-n-propylthiazolidine-4(R)-carboxylic acid will be discussed.
Keywords: glutathione, menadione, buthionine, sulfoximine, acetominophen, vitamin d, mcf cells, enterocytes, glutathione monoester, calcium absorption
Current Enzyme Inhibition
Title: Cellular and Biochemical Alterations Caused by Artificial Depletion of Glutathione
Volume: 1 Issue: 2
Author(s): N. Tolosa de Talamoni, A. Marchionatti, G. Diaz de Barboza and A. Perez
Affiliation:
Keywords: glutathione, menadione, buthionine, sulfoximine, acetominophen, vitamin d, mcf cells, enterocytes, glutathione monoester, calcium absorption
Abstract: This review will focus on glutathione depletion performed in different biological systems to elucidate molecular implications of this tripeptide on physiological and pathological processes. Cellular and molecular changes produced in liver, brain and kidney by glutathione depleting drugs, such as D,Lbuthionine- S,R-sulfoximine, menadione and acetaminophen, will be described. Special attention will be given to the inhibitory mechanisms produced by those drugs on intestinal calcium absorption and alkaline phosphatase activity. The role of DL-buthionine-S,R-sulfoximine and menadione on mechanisms of apoptosis, reactive oxygen species production and mitochondrial function from mammalian breast cancer cells will be analyzed. Finally, reversion or prevention of some of the previous effects by administration of lipoic acid, glutathione monoester, KR31378 and 2(RS)-n-propylthiazolidine-4(R)-carboxylic acid will be discussed.
Export Options
About this article
Cite this article as:
Talamoni Tolosa de N., Marchionatti A., Barboza Diaz de G. and Perez A., Cellular and Biochemical Alterations Caused by Artificial Depletion of Glutathione, Current Enzyme Inhibition 2005; 1 (2) . https://dx.doi.org/10.2174/1573408054022216
DOI https://dx.doi.org/10.2174/1573408054022216 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Retinol-Binding Protein 4 and New Adipocytokines in Nonalcoholic Fatty Liver Disease
Current Pharmaceutical Design Anti-Diarrheal Drug Repositioning in Tumour Cell Cytotoxicity
Anti-Cancer Agents in Medicinal Chemistry Cytokines in the Central Nervous System: Targets for Therapeutic Intervention
Current Drug Targets - CNS & Neurological Disorders A Glucuronic Acid Binding Leguminous Lectin with Mitogenic Activity Toward Mouse Splenocytes
Protein & Peptide Letters Pharmacological Strategies to Increase the Antitumor Activity of Methylating Agents
Current Medicinal Chemistry Recent Advances in Use of Topoisomerase Inhibitors in Combination Cancer Therapy
Current Topics in Medicinal Chemistry Prevention of Cardiovascular Diseases with Anti-Inflammatory and Anti- Oxidant Nutraceuticals and Herbal Products: An Overview of Pre-Clinical and Clinical Studies
Recent Patents on Inflammation & Allergy Drug Discovery Structure and Function of CW Domain Containing Proteins
Current Protein & Peptide Science Novel Scopoletin Derivatives Kill Cancer Cells by Inducing Mitochondrial Depolarization and Apoptosis
Anti-Cancer Agents in Medicinal Chemistry Flavaglines: Their Discovery from Plants Used in Traditional Chinese Medicine, Synthesis, and Drug Development Against Cancer and Immune Disorders
Current Chinese Chemistry Extranodal Marginal Zone B-Cell Lymphoma of Mucosa Associated Lymphoid Tissue Presenting as Multiple Pulmonary Lesions: Case Report and Review of the Literature
Current Respiratory Medicine Reviews Nanoparticulate Drug Delivery System to Overcome the Limitations of Conventional Curcumin in the Treatment of Various Cancers: A Review
Drug Delivery Letters A Network-Based Cancer Drug Discovery: From Integrated Multi-Omics Approaches to Precision Medicine
Current Pharmaceutical Design Histamine and Histamine Receptor Antagonists in Cancer Biology
Inflammation & Allergy - Drug Targets (Discontinued) Nanocarriers in Improved Heparin Delivery: Recent Updates
Current Pharmaceutical Design High-density Lipoprotein, Vascular Risk, Cancer and Infection: A Case of Quantity and Quality?
Current Medicinal Chemistry Anti-Cancer Drugs Targeting Fatty Acid Synthase (FAS)
Recent Patents on Anti-Cancer Drug Discovery Structure-Affinity-Relationship Study of Bicyclic σ Receptor Ligands
Central Nervous System Agents in Medicinal Chemistry The Vicious Circle of Leptin and Obesity
Current Nutrition & Food Science Co-targeting EGFR and Autophagy Impairs Ovarian Cancer Cell Survival during Detachment from the ECM
Current Cancer Drug Targets